Navigation Links
Embryonic selection of sex avoids conceiving blind children

The Assisted Reproduction Unit at the Quirón Hospital in Donostia-San Sebastián has managed, for the first time in the Basque Country, to successfully carry out an embryonic sex selection in a woman who is a carrier of the disease Retinosis Pigmentaria, linked with the X chromosome ?in order to avoid giving birth to a male child.

Retinosis Pigmentaria is a hereditary illness of the eyes of a degenerative nature. It causes a serious reduction in visual capacity and, in many cases, leads to blindness. The ailment does not affect males and females equally: in the case of men, there is a 50% probability of suffering the disease. With women, however, they born healthy, bat there is a 50% probability of being carriers.

The embryonic selection of sex is the only recourse open in order to avoid male children suffering from the disease with the consequent possibility of going blind. This is because, in order to select healthy embryos in a manner that does not involve sex selection, it would be essential to know the exact mutation in the chromosome, something which has not been achieved in this particular case.

This embryonic selection enables the prevention of the transmission of this disease to future generations and may be a way to reduce the number of victims of Retinosis Pigmentaria. In Spain the number of sufferers is over 15,000, with some 60,000 being carriers of the defective gene and, thereby, possible transmitters of the condition.


'"/>

Source:Elhuyar Fundazioa


Page: 1

Related biology news :

1. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
2. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
3. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers
4. Embryonic stem cells accrue genetic changes
5. Embryonic stem cells do better on bumpy nanoscale mattress
6. Embryonic patterning makes the feathers fly
7. An entropy-based gene selection method for cancer classification using microarray data
8. Cornell finds natural selection in humans
9. Natural selection at single gene demonstrated
10. Does natural selection drive the evolution of cancer?
11. Pressured by predators, lizards see rapid shift in natural selection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:11/30/2016)... Nov. 30, 2016  higi SH llc (higi) ... initiative targeting national brands, industry thought-leaders and celebrity ... respective audiences for taking steps to live healthier, ... in 2012, higi has built the largest self-screening ... 38 million people who have conducted over 185 ...
(Date:11/28/2016)... Nov. 28, 2016 "The ... of 16.79%" The biometric system market is in ... in the near future. The biometric system market is ... 2022, at a CAGR of 16.79% between 2016 and ... of biometric technology in smartphones, rising use of biometric ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Savannah River Remediation LLC group evaluated ... NT-MAX Lake & Pond Sludge and Muck ... conjunction with Hexa Armor/ Rhombo cover manufactured by ... Discharge Elimination System requirements. The Savannah ... of elevated pH levels, above 8.5, especially during ...
(Date:12/8/2016)... Dec. 8, 2016  Partnering to fuel ... Technology Partners of Southeastern Pennsylvania ... parent company of Independence Blue Cross; and Safeguard Scientifics ... intentions for a $6 million funding initiative over a ... Responding to a burgeoning economic vitality in ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology: